JPD is an Open Acces journalJPD, new EICSpecial Issue: Linking Immune Activation and Parkinson’s DiseaseFrozen AddictsThe Importance of the World Parkinson Congress for People with Parkinson’sThe International Linked Clinical Trials Initiative: A Program of Hope for Parkinson’s DiseasePatient’s Perspective - The Will to Live a Good Life

New Co-Editor-in-Chief Appointed
Lorraine V. Kalia, MD, PhD, FRCPC, an Associate Professor and Clinician Scientist in the Division of Neurology at the University of Toronto and a Senior Scientist at the Krembil Research Institute of the University Health Network, joins JPD! Click for details.

New Blog Written by Sharon Krischer
Going to the World Parkinson Congress for the first time can be an exciting challenge for a person with Parkinson’s disease. On the one hand, there is so much to see and do it is almost like a Disneyland for People with Parkinson’s. On the other hand, how do you fit everything into 3,5 days? Somehow, executive director Elizabeth (Eli) Pollard and her team managed to bring together an amazing international conference that is inspiring, educational and welcoming to all in the Parkinson’s community.

New Blog Written by Frank C. Church, PhD
Cure Parkinson's (CP) started the international Linked Clinical Trials (iLCT) initiative to repurpose drugs for the treatment of Parkinson's disease (PD). Combining priorities with the Van Andel Institute (VAI), they hold an annual two-day meeting to present, examine, discuss, and prioritize suitable compounds for streamlining into clinical trials specifically for slowing down/stopping/reversing the progression of PD.

New Patient’s Perspective Written by Sharon Chakkalackal
"This is my journey of how I came to be diagnosed with Young Onset Parkinson’s Disorder (YOPD) symptoms at the age of 38."

Watch the latest recording of our Quarterly Parkinson's Webinars by clicking above or here, and discover all about the webinar series & watch all recordings here!

16 December 2022

Journal of Parkinson’s Disease Awards 2022 Parkinson Prize

The Journal of Parkinson’s Disease and its publisher IOS Press are proud to announce the two articles that have won the 2022 Parkinson Prize. The authors of these articles are being recognized for their outstanding contributions to the advancement of Parkinson’s disease (PD) research. Recipients of the award are co-authors Thomas G. Beach, MD, PhD, FRCPC, Banner Sun Health Research Institute, and Charles H. Adler, MD, PhD, FAAN, Mayo Clinic Arizona (basic research article), and Simon Stott, PhD, Cure Parkinson’s (clinical research article).

Subscribe to Journal of Parkinson's Disease RSS